Psilocybin for Methamphetamine Use Disorder

Summary

This trial tests whether psilocybin-assisted treatment can help adults stop using methamphetamine. Participants receive a single oral dose of psilocybin during a supervised session, paired with brief cognitive behavioral therapy, and are followed for up to six months. The study is supported by the HEAL Initiative (https://www.nih.gov/heal).

Timeline

Start

2027-02-01

Primary completion

2032-02-01

Completion

2032-02-01

Drugs

Indications